Alzheimers Dement

1. 
   Alzheimer's Association and ASNR announce recipients of imaging grants.
   Alzheimers Dement. 2024;20:1476-1477.
   

   >> Share

   
   
2. XICOTA L, Cosentino S, Vardarajan B, Mayeux R, et al
   Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease.
   Alzheimers Dement. 2024 Feb 21. doi: 10.1002/alz.13718.
   

   >> Share

   
   
3. WOLTERS FJ, Labrecque JA
   Potential impact of unblinding on observed treatment effects in Alzheimer's disease trials.
   Alzheimers Dement. 2024 Feb 21. doi: 10.1002/alz.13690.
   

   >> Share

   
   
4. FERGUSON CM, Hildebrand S, Godinho BMDC, Buchwald J, et al
   Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.
   Alzheimers Dement. 2024 Feb 20. doi: 10.1002/alz.13703.
   

   >> Share

   
   
5. ORTEGA-CRUZ D, Bress KS, Gazula H, Rabano A, et al
   Three-dimensional histology reveals dissociable human hippocampal long-axis gradients of Alzheimer's pathology.
   Alzheimers Dement. 2024 Feb 18. doi: 10.1002/alz.13695.
   

   >> Share

   
   
6. CLARK AL, Thomas KR, Ortega N, Haley AP, et al
   Empirically derived psychosocial-behavioral phenotypes in Black/African American and Hispanic/Latino older adults enrolled in HABS-HD: Associations with AD biomarkers and cognitive outcomes.
   Alzheimers Dement. 2024;20:1360-1373.
   

   >> Share

   
   
7. EISSMAN JM, Archer DB, Mukherjee S, Lee ML, et al
   Sex-specific genetic architecture of late-life memory performance.
   Alzheimers Dement. 2024;20:1250-1267.
   

   >> Share

   
   
8. SLEE MG, Rainey-Smith SR, Villemagne VL, Doecke JD, et al
   Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults.
   Alzheimers Dement. 2024;20:1350-1359.
   

   >> Share

   
   
9. COGSWELL PM, Lundt ES, Therneau TM, Wiste HJ, et al
   Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET.
   Alzheimers Dement. 2024;20:1225-1238.
   

   >> Share

   
   
10. BUTTS B, Huang H, Hu WT, Kehoe PG, et al
    sPDGFRbeta and neuroinflammation are associated with AD biomarkers and differ by race: The ASCEND Study.
    Alzheimers Dement. 2024;20:1175-1189.
    

    >> Share

    
    
11. CHEN H, Dunk MM, Wang B, Zhao M, et al
    Associations of the Mediterranean-DASH Intervention for Neurodegenerative Delay diet with brain structural markers and their changes.
    Alzheimers Dement. 2024;20:1190-1200.
    

    >> Share

    
    
12. WOO MS, Tissot C, Lantero-Rodriguez J, Snellman A, et al
    Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-beta positive individuals.
    Alzheimers Dement. 2024;20:1166-1174.
    

    >> Share

    
    
13. ACKLEY SF, Wang J, Chen R, Power MC, et al
    Estimated effects of amyloid reduction on cognitive change: A Bayesian update across a range of priors.
    Alzheimers Dement. 2024;20:1149-1155.
    

    >> Share

    
    
14. SANFORD SAI, Miller LVC, Vaysburd M, Keeling S, et al
    The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology.
    Alzheimers Dement. 2024;20:1013-1025.
    

    >> Share

    
    
15. GERMAN-CASTELAN L, Shanks HRC, Gros R, Saito T, et al
    Sex-dependent cholinergic effects on amyloid pathology: A translational study.
    Alzheimers Dement. 2024;20:995-1012.
    

    >> Share

    
    
16. SCHWEITZER N, Li J, Thurston RC, Lopresti B, et al
    Sex-dependent alterations in hippocampal connectivity are linked to cerebrovascular and amyloid pathologies in normal aging.
    Alzheimers Dement. 2024;20:914-924.
    

    >> Share

    
    
17. AARONSON A, Ashford MT, Jin C, Bride J, et al
    Brain Health Registry Study Partner Portal: Novel infrastructure for digital, dyadic data collection.
    Alzheimers Dement. 2024;20:846-857.
    

    >> Share

    
    
18. MARINO C, Perez-Corredor P, O'Hare M, Heuer A, et al
    APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation.
    Alzheimers Dement. 2024;20:819-836.
    

    >> Share

    
    
19. TATE AE, Bouteloup V, van Maurik IS, Jean D, et al
    Predicting sojourn times across dementia disease stages, institutionalization, and mortality.
    Alzheimers Dement. 2024;20:809-818.
    

    >> Share

    
    
20. SHI H, Koronyo Y, Fuchs DT, Sheyn J, et al
    Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients.
    Alzheimers Dement. 2023;19:5185-5197.
    

    >> Share

    
    

    
    Am J Geriatr Psychiatry

21. SISTI A, Gutman R, Mor V, Dionne L, et al
    Using Structured Observations to Evaluate the Effects of a Personalized Music Intervention on Agitated Behaviors and Mood in Nursing Home Residents With Dementia: Results From an Embedded, Pragmatic Randomized Controlled Trial.
    Am J Geriatr Psychiatry. 2024;32:300-311.
    

    >> Share

    
    

    
    BMC Neurol

22. YE S, Roccati E, Wang W, Zhu Z, et al
    Leading determinants of incident dementia among individuals with and without the apolipoprotein E epsilon4 genotype: a retrospective cohort study.
    BMC Neurol. 2024;24:71.
    

    >> Share

    
    

    
    Brain Res

23. MANTELLATTO GRIGOLI M, Pelegrini LNC, Whelan R, Cominetti MR, et al
    Present and Future of Blood-Based Biomarkers of Alzheimer's Disease: Beyond the Classics.
    Brain Res. 2024;1830:148812.
    

    >> Share

    
    

    
    J Alzheimers Dis

24. FINCH CE, Burstein SM
    Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.
    J Alzheimers Dis. 2024;97:1581-1588.
    

    >> Share

    
    
25. CUI X, Wang J, Wu B, Zhao Q, et al
    Interventions for Persons with Young-Onset Dementia and Their Families: A Scoping Review.
    J Alzheimers Dis. 2024;97:1519-1531.
    

    >> Share

    
    
26. ARMSTRONG MJ, Barnes LL
    Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors.
    J Alzheimers Dis. 2024;97:1571-1580.
    

    >> Share

    
    
27. GROECHEL RC, Liu AC, Koton S, Kucharska-Newton AM, et al
    Associations Between Mid-Life Psychosocial Measures and Estimated Late Life Amyloid Burden: The Atherosclerosis Risk in Communities (ARIC)-PET Study.
    J Alzheimers Dis. 2024;97:1901-1911.
    

    >> Share

    
    
28. BACHAND AM, Dell LD
    Can Incorrect Analysis of Time-Dependent Exposure Explain Associations between PM2.5 Exposure and Risk of Dementia?
    J Alzheimers Dis. 2024;97:1931-1937.
    

    >> Share

    
    
29. VERMEULEN RJ, Roudijk B, Govers TM, Rovers MM, et al
    Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life.
    J Alzheimers Dis. 2024;97:1829-1840.
    

    >> Share

    
    
30. HARRIS JL, Wang X, Christian SK, Novikova L, et al
    Traumatic Brain Injury Alters the Trajectory of Age-Related Mitochondrial Change.
    J Alzheimers Dis. 2024;97:1793-1806.
    

    >> Share

    
    
31. VALENCIA-OLVERA AC, Balu D, Moore A, Shah M, et al
    APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice.
    J Alzheimers Dis. 2024;97:1629-1639.
    

    >> Share

    
    
32. ZHANG S, Ai H, Wang J, Liu T, et al
    Reduced Prefrontal-Thalamic Theta Flow During Working Memory Retrieval in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:1737-1749.
    

    >> Share

    
    
33. DAI Y, Hsu YC, Fernandes BS, Zhang K, et al
    Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
    J Alzheimers Dis. 2024;97:1807-1827.
    

    >> Share

    
    
34. HEIKKINEN AL, Paajanen TI, Hanninen T, Tikkanen V, et al
    Neuropsychological Profiles, Etiologies, and Medical Comorbidities in Early-Onset Dementia and Cognitive Impairment: A Memory Outpatient Clinic Cohort Study.
    J Alzheimers Dis. 2024;97:1765-1776.
    

    >> Share

    
    
35. VESTIN E, Bostrom G, Olsson J, Elgh F, et al
    Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study.
    J Alzheimers Dis. 2024;97:1841-1850.
    

    >> Share

    
    

    
    J Am Geriatr Soc

36. RONCARATI JS, DeVone F, Halladay C, Tsai J, et al
    Risk of dementia among veterans experiencing homelessness and housing instability.
    J Am Geriatr Soc. 2024;72:382-389.
    

    >> Share

    
    
37. HANSON LC, Wessell K, Meeks N, Bennett AV, et al
    Selecting outcomes for pragmatic clinical trials in dementia care: The IMPACT Collaboratory iLibrary.
    J Am Geriatr Soc. 2024;72:529-535.
    

    >> Share

    
    

    
    J Neurochem

38. ZHANG JF, Fang ZT, Zhao JN, Liu GP, et al
    Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells.
    J Neurochem. 2024;168:288-302.
    

    >> Share

    
    
39. HANRIEDER J
    Lipid imaging of Alzheimer's disease pathology.
    J Neurochem. 2024 Feb 19. doi: 10.1111/jnc.16079.
    

    >> Share

    
    
40. PEREIRA JD, Teixeira LCR, Mamede I, Alves MT, et al
    miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach.
    J Neurochem. 2024 Feb 23. doi: 10.1111/jnc.16060.
    

    >> Share

    
    

    
    J Neurol

41. ST-GEORGES MA, Wang L, Chapleau M, Migliaccio R, et al
    Social cognition and behavioral changes in patients with posterior cortical atrophy.
    J Neurol. 2023 Nov 30. doi: 10.1007/s00415-023-12089.
    

    >> Share

    
    

    
    J Neurosci

42. MABOUDIAN SA, Willbrand EH, Jagust WJ, Weiner KS, et al
    Defining overlooked structures reveals new associations between cortex and cognition in aging and Alzheimer's disease.
    J Neurosci. 2024 Feb 21:e1714232024. doi: 10.1523/JNEUROSCI.1714-23.2024.
    

    >> Share

    
    
43. ZHOU J, Wearn A, Huck J, Hughes C, et al
    Iron deposition and distribution across the hippocampus is associated with pattern separation and pattern completion in older adults at risk for Alzheimer's disease.
    J Neurosci. 2024 Feb 22:e1973232024. doi: 10.1523/JNEUROSCI.1973-23.2024.
    

    >> Share

    
    

    
    Lancet Neurol

44. THE LANCET NEUROLOGY
    Dementia diagnosis in the anti-amyloid era.
    Lancet Neurol. 2024;23:219.
    

    >> Share

    
    
45. FRISONI GB, Festari C, Massa F, Cotta Ramusino M, et al
    European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders.
    Lancet Neurol. 2024;23:302-312.
    

    >> Share

    
    

    
    N Engl J Med

46. MAYEUX R
    Alzheimer's Disease Biomarkers - Timing Is Everything.
    N Engl J Med. 2024;390:761-763.
    

    >> Share

    
    
47. JIA J, Ning Y, Chen M, Wang S, et al
    Biomarker Changes during 20 Years Preceding Alzheimer's Disease.
    N Engl J Med. 2024;390:712-722.
    

    >> Share

    
    

    
    Nat Med

48. BARTHELEMY NR, Salvado G, Schindler S, He Y, et al
    Highly Accurate Blood Test for Alzheimer's Disease Comparable or Superior to Clinical CSF Tests.
    Nat Med. 2024 Feb 21. doi: 10.1038/s41591-024-02869.
    

    >> Share

    
    

    
    Nat Rev Neurol

49. GOTZ J, Padmanabhan P
    Ultrasound and antibodies - a potentially powerful combination for Alzheimer disease therapy.
    Nat Rev Neurol. 2024 Feb 20. doi: 10.1038/s41582-024-00943.
    

    >> Share

    
    

    
    Nat Rev Neurosci

50. SLUTSKY I
    Linking activity dyshomeostasis and sleep disturbances in Alzheimer disease.
    Nat Rev Neurosci. 2024 Feb 19. doi: 10.1038/s41583-024-00797.
    

    >> Share

    
    

    
    Neurobiol Aging

51. SIMON SS, Varangis E, Lee S, Gu Y, et al
    In vivo tau is associated with change in memory and processing speed, but not reasoning, in cognitively unimpaired older adults.
    Neurobiol Aging. 2024;133:28-38.
    

    >> Share

    
    
52. TWITTO-GREENBERG R, Liraz-Zaltsman S, Michaelson DM, Liraz O, et al
    9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models.
    Neurobiol Aging. 2024;133:16-27.
    

    >> Share

    
    

    
    Neurochem Res

53. XIAO X, Rui Y, Jin Y, Chen M, et al
    Relationship of Sleep Disorder with Neurodegenerative and Psychiatric Diseases: An Updated Review.
    Neurochem Res. 2024;49:568-582.
    

    >> Share

    
    

    
    Neurology

54. FLEISHER AS, Munsie LM, Perahia DGS, Andersen SW, et al
    Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease.
    Neurology. 2024;102:e208061.
    

    >> Share

    
    
55. CHRISTENSEN GM, Li Z, Liang D, Ebelt S, et al
    Association of PM(2.5) Exposure and Alzheimer Disease Pathology in Brain Bank Donors-Effect Modification by APOE Genotype.
    Neurology. 2024;102:e209162.
    

    >> Share

    
    
56. HONIG M, Altomare D, Caprioglio C, Collij L, et al
    Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
    Neurology. 2024;102:e208053.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share